首页 | 本学科首页   官方微博 | 高级检索  
     


Use of intravenous antiarrhythmics to identify concealed Brugada syndrome
Authors:Ramon Brugada
Affiliation:1. Duke University Medical Center, Durham, North Carolina, USA
2. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
Abstract:November's Institute of Medicine (IOM) report on medical errors has sparked debate among US health policy makers as to the appropriate response to the problem. Proposals range from the implementation of nationwide mandatory reporting with public release of performance data to voluntary reporting and quality-assurance efforts that protect the confidentiality of error-related data. Any successful safety program will require a national effort to make significant investments in information technology infrastructure, and to provide an environment and education that enables providers to contribute to an active quality-improvement process.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号